CONNECT BIOPHARMA HOLDINGS L
Develops gene therapy treatments for diseases.
Stock Performance Snapshot
Analyst Rating
Analysts strongly recommend buying CONNECT BIOPHARMA's stock, expecting its price to rise significantly.
Financial Health
CONNECT BIOPHARMA HOLDINGS L has modest revenue and cash flow, indicating a stable but cautious outlook.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CNTB
The Plasma Profit Pipeline
Biopharmaceutical leader CSL reported a 14% surge in annual profit, fueled by its plasma division's success. This highlights a growing investment opportunity in companies involved in the plasma-derived therapies market and the broader bioprocessing supply chain.
Published: August 19, 2025
Explore BasketChina's Biopharma Innovators: The Next Global Partnership Wave
Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.
Published: July 28, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Clinical Catalysts Ahead
Upcoming trial readouts and regulatory milestones can create sharp price moves; they may present opportunity but also significant downside if results are unfavourable.
Volatility & Financing Risk
Small‑cap biotechs often face dilution to fund operations and can experience wide swings in value. Check cash runway and recent financing history.
Partnerships Matter
Licensing or collaborations with larger firms can de‑risk programmes and unlock value, though such deals are not guaranteed.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals develops treatments for diseases including cystic fibrosis and cancer.
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals is a leading biotechnology company that develops and manufactures innovative medicines for serious medical conditions.
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing and commercializing therapeutics based on RNA interference (RNAi).
